acetaminophen has been researched along with feprazone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Fletcher, MR; Loebl, W; Scott, JT | 1 |
2 trial(s) available for acetaminophen and feprazone
Article | Year |
---|---|
[Symptomatic treatment of acute inflammation of the upper respiratory airways in pediatrics].
Topics: Acetaminophen; Acute Disease; Analgesics; Animals; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Female; Feprazone; Guaifenesin; Humans; Infant; Male; Phenylbutazone; Rabbits; Respiratory Tract Infections; Suppositories | 1977 |
Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance.
Topics: Acetaminophen; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Digestive System; Female; Feprazone; Hemoglobinometry; Humans; Male; Middle Aged; Nausea; Pain; Phenylbutazone; Skin Diseases; Sleep; Vomiting | 1975 |
2 other study(ies) available for acetaminophen and feprazone
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |